ATAD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.047600E-01
Normal-vs-Stage2
5.475800E-01
Normal-vs-Stage3
6.536600E-01
Normal-vs-Stage4
7.562600E-01
Stage1-vs-Stage2
6.058200E-01
Stage1-vs-Stage3
3.650600E-01
Stage1-vs-Stage4
8.826000E-01
Stage2-vs-Stage3
2.477400E-01
Stage2-vs-Stage4
7.801600E-01
Stage3-vs-Stage4
3.553000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.493600E-01
Normal-vs-AfricanAmerican
9.006600E-01
Normal-vs-Asian
7.568600E-01
Caucasian-vs-AfricanAmerican
4.768800E-01
Caucasian-vs-Asian
5.023600E-01
AfricanAmerican-vs-Asian
7.763600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.735600E-01
Normal-vs-Female
5.508600E-01
Male-vs-Female
8.659600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.065200E-01
Normal-vs-Age(41-60Yrs)
4.007000E-01
Normal-vs-Age(61-80Yrs)
6.409000E-01
Normal-vs-Age(81-100Yrs)
7.318800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.993560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.836400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.135000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.324500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.487800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.972200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.832200E-01
Normal-vs-Daily Drinker
7.049400E-01
Normal-vs-Weekly Drinker
6.297200E-01
Normal-vs-Occasional Drinker
4.020000E-01
Normal-vs-Social Drinker
5.539000E-01
Non Drinker-vs-Daily Drinker
8.513000E-01
Non Drinker-vs-Weekly Drinker
9.971000E-01
Non Drinker-vs-Occasional Drinker
3.503000E-01
Non Drinker-vs-Social Drinker
8.519800E-01
Daily Drinker-vs-Weekly Drinker
8.576600E-01
Daily Drinker-vs-Occasional Drinker
2.614400E-01
Daily Drinker-vs-Social Drinker
7.035600E-01
Weekly Drinker-vs-Occasional Drinker
3.980400E-01
Weekly Drinker-vs-Social Drinker
8.545600E-01
Occasional Drinker-vs-Social Drinker
4.840200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.927600E-01
Normal-vs-Grade 2
8.389400E-01
Normal-vs-Grade 3
9.626400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.186600E-01
Grade 1-vs-Grade 3
1.632130E-02
Grade 1-vs-Grade 4
7.927600E-01
Grade 2-vs-Grade 3
3.304000E-02
Grade 2-vs-Grade 4
8.389400E-01
Grade 3-vs-Grade 4
9.626400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.123800E-01
Normal-vs-NonDiabetic
5.696200E-01
Diabetic-vs-NonDiabetic
5.141600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.222400E-01
Normal-vs-NoPancreatitis
5.907600E-01
Pancreatitis-vs-NoPancreatitis
8.472600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.050000E-01
Normal-vs-N1
5.667400E-01
N0-vs-N1
9.322000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.641040E-01
Normal-vs-TP53-NonMutant
5.367800E-01
TP53-Mutant-vs-TP53-NonMutant
7.99510000000225E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
